Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis

By Setyawan Juliana  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 962-975

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population

By Christensen Laura   Sasané Rahul   Hodgkins Paul   Harley Carolyn   Tetali Srinivas  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 977-989

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity

By Ginsberg Lawrence   Katic Alain   Adeyi Ben   Dirks Bryan   Babcock Thomas   Lasser Robert   Scheckner Brian   Adler Lenard A.  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1097-1107

Informa Healthcare

Access to resources Recommend Favorite

Amphetamine‐induced chorea in attention deficit–hyperactivity disorder

By  

MOVEMENT DISORDERS, Vol. 19, Iss. 7, 2004-07 ,pp. : 840-842

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

By Montoya Alonso   Hervas Amaia   Cardo Esther   Artigas Josep   Mardomingo María J.   Alda José A.   Gastaminza Xavier   García-Polavieja María J.   Gilaberte Inmaculada   Escobar Rodrigo  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2745-2754

Informa Healthcare

Access to resources Recommend Favorite